Abdelhamid Benazzouz is a Neurophysiologist Researcher working in Bordeaux University. He is expert in the field of Neuroscience and especially in Parkinson’s disease. He was the first to develop high frequency stimulation (HFS) of the subthalamic nucleus (STN) as a therapeutical approach of Parkinson’s disease in MPTP monkeys and participated to its transfer to parkinsonian patients with Benabid and Pollak. In 2005 he was promoted to Inserm Research Director position. He is leading the Team "Neurochemistry, Deep Brain Stimulation & Parkinson’s disease" in the Institute of Neurodegenerative diseases in Bordeaux University. He has published more than 120 research papers with more than 15 thousand citations and received 55 degrees on the global H-Index. He obtained the National Academy of Medicine award in 2003 and the Academy of Science award in 2007. In 2010, He obtained the distinction of Scientific Excellence delivered by Inserm.
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. OkPrivacy policy